Desq Long
Sign in
SEC FORM 4
$0.00

TScan Therapeutics, Inc. (TCRX)

Acquisition (code A) of 1,000,000 shares at $0.00 per share.

Reporting Person MacBeath Gavin · Officer Title Chief Executive Officer · Transaction Code A

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001193125-26-412521 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TScan Therapeutics, Inc. (TCRX)." Disclosed 2026-10-02. https://desqlong.com/cards/0001193125-26-412521-1 (retrieved 2026-10-03).